|
|
|
Volumn 63 Suppl 11, Issue , 2005, Pages 421-425
|
|
Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
AMOXICILLIN;
ANTIINFECTIVE AGENT;
CLARITHROMYCIN;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
LANSOPRAZOLE;
METRONIDAZOLE;
OMEPRAZOLE;
PROTON PUMP;
ANTIBIOTIC RESISTANCE;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
MICROBIOLOGICAL EXAMINATION;
PATIENT COMPLIANCE;
REVIEW;
TREATMENT OUTCOME;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
AMOXICILLIN;
ANTI-BACTERIAL AGENTS;
CLARITHROMYCIN;
DRUG RESISTANCE, BACTERIAL;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
METRONIDAZOLE;
MICROBIAL SENSITIVITY TESTS;
OMEPRAZOLE;
PATIENT COMPLIANCE;
PROTON PUMPS;
TREATMENT OUTCOME;
|
|
EID: 33644834503
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (24)
|
